Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Transactivation assays from US Patent US10752616: "Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonists"
Assay data:46 Active, 2 Activity ≤ 1 nM, 46 Activity ≤ 1 µM, 46 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Retinoid Competition Binding Assay from Article 10.1006/jmbi.2000.4032: "Structural basis for isotype selectivity of the human retinoic acid nuclear receptor."
Assay data:9 Active, 3 Activity ≤ 1 nM, 9 Activity ≤ 1 µM, 9 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Agonist activity at human RAR
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Transactivation of GAL4-fused mouse RARgamma-LBD expressed in COS-7 cells after 24 hrs by bright-Glo reagent based assay
Assay data:18 Active, 2 Activity ≤ 1 nM, 18 Activity ≤ 1 µM, 20 Tested
Agonist activity at RAR (unknown origin) by Alpha Screen assay
Transactivation of mouse Gal4-fused RARgamma-LBD expressed in COS-7 cells after 1 day by bright-Glo reagent based assay
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Transactivation of mouse Gal4-fused RARbeta-LBD expressed in COS-7 cells after 1 day by bright-Glo reagent based assay
Drug repurposing screens with cells derived from glioblastoma tumor samples
Assay data:1237 Active, 3 Activity ≤ 1 nM, 360 Activity ≤ 1 µM, 3733 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µM
BK Channel Variant Modulator Selectivity Assay
Assay data:286 Active, 904 Activity ≤ 1 nM, 951 Activity ≤ 1 µM, 951 Tested
Inhibition of ROR beta (unknown origin)-mediated transactivation
Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB
Assay data:3916 Active, 206 Activity ≤ 1 nM, 1830 Activity ≤ 1 µM, 3916 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Activity at human RARgamma ligand binding domain expressed in COS7 cells co-transfected with Gal4-DBD assessed as transcriptional activation after 16 hrs by Gal4 response element-driven luciferase reporter gene assay
Assay data:6 Active, 2 Activity ≤ 1 nM, 10 Activity ≤ 1 µM, 10 Tested
Induction of terminal differentiation in mouse F9 cells assessed by measuring secreted plasminogen activator activity after 3 days
Assay data:4 Active, 3 Activity ≤ 1 nM, 4 Activity ≤ 1 µM, 5 Tested
Reversal of keratinization in vitamin A-deficient hamster trachea after 10 days by TOC assay
Assay data:4 Active, 4 Activity ≤ 1 nM, 4 Activity ≤ 1 µM, 5 Tested
Dissociation constant for Retinoic acid receptor gamma
Assay data:4 Active, 2 Activity ≤ 1 nM, 4 Activity ≤ 1 µM, 6 Tested
Binding affinity towards cRAR-beta-2 receptor by displacing 1.1 nM 3[H]-9-cis-RA
Assay data:2 Active, 1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 3 Tested
Binding affinity towards cRARbeta2 receptor by displacing 0.82 nM 3[H]all-trans-RA
Inhibitory dose against tracheal organ culture reversal of keratinization
Assay data:7 Active, 8 Activity ≤ 1 nM, 9 Activity ≤ 1 µM, 9 Tested
Inhibition of [3H]-9-cis RA binding to Retinoid X receptor RXR gamma
Assay data:3 Active, 1 Activity ≤ 1 nM, 4 Activity ≤ 1 µM, 4 Tested
Inhibition of [3H]-9-cis RA binding to Retinoid X receptor RXR beta
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on